Bmi-1 Regulates Stem Cell-like Properties of Gastric Cancer Cells Via Modulating MiRNAs

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2016 Sep 21

PMID 27644439

Citations 39

Authors

Xiaofeng Wang

Chang Wang

Xiaowei Zhang

Ruixi Hua

Lu Gan

Mingzhu Huang

Liqin Zhao

Sujie Ni

Weijian Guo

Affiliations

Soon will be listed here.

Abstract

Background: B cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) plays an important role in regulating stemness in some kinds of cancer. However, the mechanisms remain unclear. This study was to investigate whether and how Bmi-1 regulates stemness of gastric cancer.

Methods: We firstly explored the role of Bmi-1 in regulating stem cell-like features in gastric cancer. Secondly, we screened out its downstream miRNAs and clarified whether these miRNAs are involved in the regulation of stemness. Finally, we investigated the mechanisms how Bmi-1 regulates miRNAs.

Results: Bmi-1 positively regulates stem cell-like properties of gastric cancer and upregulates miR-21 and miR-34a. There was a positive correlation between Bmi-1 and miR-21 expression in gastric cancer tissues. MiR-21 mediated the function of Bmi-1 in regulating stem cell-like properties, while miR-34a negatively regulates stem cell-like characteristics via downregulating Bmi-1. Bmi-1 binds to PTEN promoter and directly inhibits PTEN and thereafter activates AKT. Bmi-1 also regulates p53 and PTEN via miR-21. Bmi-1 activated NF-kB via AKT and enhanced the binding of NF-kB to the promoter of miR-21 and miR-34a and increased their expression.

Conclusions: Bmi-1 positively regulates stem cell-like properties via upregulating miR-21, and miR-34a negatively regulates stem cell-like characteristics by negative feedback regulation of Bmi-1 in gastric cancer. Bmi-1 upregulates miR-21 and miR-34a by activating AKT-NF-kB pathway.

Citing Articles

Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development.

Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A Heliyon. 2024; 10(15):e35208.

PMID: 39170516 PMC: 11337742. DOI: 10.1016/j.heliyon.2024.e35208.

Cancer stem cells: advances in knowledge and implications for cancer therapy.

Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z Signal Transduct Target Ther. 2024; 9(1):170.

PMID: 38965243 PMC: 11224386. DOI: 10.1038/s41392-024-01851-y.

Multifaceted role of microRNAs in gastric cancer stem cells: Mechanisms and potential biomarkers.

Sun Q, Kuang Z, Zhu G, Ni B, Li J World J Gastrointest Oncol. 2024; 16(2):300-313.

PMID: 38425402 PMC: 10900144. DOI: 10.4251/wjgo.v16.i2.300.

PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis.

Valenti G, Roveri A, Venerando R, Menichini P, Monti P, Tasso B Antioxidants (Basel). 2024; 13(1).

PMID: 38275623 PMC: 10812464. DOI: 10.3390/antiox13010003.

Cancer stem cells: a target for overcoming therapeutic resistance and relapse.

Zhang S, Yang R, Ouyang Y, Shen Y, Hu L, Xu C Cancer Biol Med. 2024; .

PMID: 38164743 PMC: 10845928. DOI: 10.20892/j.issn.2095-3941.2023.0333.

References

Song W, Tao K, Li H, Jin C, Song Z, Li J . Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer. Cancer Sci. 2010; 101(7):1754-60. PMC: 11159722. DOI: 10.1111/j.1349-7006.2010.01577.x. View

Chen T, Yang K, Yu J, Meng W, Yuan D, Bi F . Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res. 2011; 22(1):248-58. PMC: 3351913. DOI: 10.1038/cr.2011.109. View

Clarke M, Dick J, Dirks P, Eaves C, Jamieson C, Jones D . Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006; 66(19):9339-44. DOI: 10.1158/0008-5472.CAN-06-3126. View

Jiang L, Song L, Wu J, Yang Y, Zhu X, Hu B . Bmi-1 promotes glioma angiogenesis by activating NF-κB signaling. PLoS One. 2013; 8(1):e55527. PMC: 3561301. DOI: 10.1371/journal.pone.0055527. View

Liu S, Dontu G, Mantle I, Patel S, Ahn N, Jackson K . Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006; 66(12):6063-71. PMC: 4386278. DOI: 10.1158/0008-5472.CAN-06-0054. View

Godlewski J, Nowicki M, Bronisz A, Williams S, Otsuki A, Nuovo G . Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008; 68(22):9125-30. DOI: 10.1158/0008-5472.CAN-08-2629. View

Lu Y, Li J, Guo W . Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma. J Exp Clin Cancer Res. 2010; 29:143. PMC: 2993658. DOI: 10.1186/1756-9966-29-143. View

Rajasekhar V, Begemann M . Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells. 2007; 25(10):2498-510. DOI: 10.1634/stemcells.2006-0608. View

Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z . Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Mol Cell Biochem. 2011; 363(1-2):427-36. DOI: 10.1007/s11010-011-1195-5. View

10.

Guo B, Feng Y, Zhang R, Xu L, Li M, Kung H . Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer. 2011; 10(1):10. PMC: 3038148. DOI: 10.1186/1476-4598-10-10. View

11.

Lessard J, Sauvageau G . Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003; 423(6937):255-60. DOI: 10.1038/nature01572. View

12.

Liu J, Malavya S, Wang X, Saavedra J, Keefer L, Tokar E . Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells. Genomics. 2009; 94(1):32-8. PMC: 3496159. DOI: 10.1016/j.ygeno.2009.03.005. View

13.

Liu Z, Liu L, Xu L, Yi W, Tao Y, Tu Z . Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Oncol Rep. 2012; 27(4):1116-22. PMC: 3583403. DOI: 10.3892/or.2011.1615. View

14.

Li J, Wang K, Chen X, Meng H, Song M, Wang Y . Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol Biol. 2012; 13:4. PMC: 3311059. DOI: 10.1186/1471-2199-13-4. View

15.

Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H . Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol. 2010; 36(5):1089-95. DOI: 10.3892/ijo_00000590. View

16.

Li W, Ma M, Dong L, Wang F, Chen L, Li X . MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol Ther. 2011; 12(6):477-83. DOI: 10.4161/cbt.12.6.16300. View

17.

Goel G, Sun W . Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade. J Hematol Oncol. 2015; 8:86. PMC: 4502562. DOI: 10.1186/s13045-015-0185-6. View

18.

Fukuda K, Saikawa Y, Ohashi M, Kumagai K, Kitajima M, Okano H . Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol. 2009; 34(5):1201-7. View

19.

Takaishi S, Okumura T, Tu S, Wang S, Shibata W, Vigneshwaran R . Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009; 27(5):1006-20. PMC: 2746367. DOI: 10.1002/stem.30. View

20.

Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B . Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res. 2009; 16(1):45-55. PMC: 2874875. DOI: 10.1158/1078-0432.CCR-09-1630. View